会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 73. 发明申请
    • Medication Adherence Monitoring System
    • 药物依从性监测系统
    • US20100255598A1
    • 2010-10-07
    • US12064673
    • 2008-02-22
    • Richard J. MelkerDonn Michael DennisChristopher D. BatichMark S. Gold
    • Richard J. MelkerDonn Michael DennisChristopher D. BatichMark S. Gold
    • G01N33/50
    • G01N33/58A61B5/083A61B5/411A61B5/4833A61K49/0004A61K51/1206G01N2458/15Y10T436/22
    • The present invention relates to the detection of markers in exhaled breath, wherein the detection of the presence or absence of the marker(s) in exhaled breath is used to assess various clinical data, including patient adherence in taking the medication and patient enzymatic (metabolic) competence in metabolizing the medication. An embodiment of the invention comprises a parent therapeutic agent labeled with a marker, where upon metabolism (e.g., via enzymatic action) of the therapeutic agent, the marker becomes volatile or semi-volatile and is present in the breath. In certain related embodiments, the marker contain a deuterium label, which is also present in the breath upon metabolism of the therapeutic agent. In another embodiment of the invention, the therapeutic agent is associated with a taggant (that may be either labeled or unlabeled with deuterium), which in turn will generate a marker in the breath that is easily measurable.
    • 本发明涉及呼出呼吸中的标记物的检测,其中使用呼出呼吸中标记物的存在或不存在来检测各种临床数据,包括患者服用药物和患者酶促代谢(代谢 )代谢药物的能力。 本发明的一个实施方案包括用标记物标记的母体治疗剂,其中当代谢(例如通过酶促作用)治疗剂时),标记物变得挥发性或半挥发性并且存在于呼吸中。 在某些相关实施方案中,标记物含有氘标记,其在治疗剂代谢时也存在于呼吸中。 在本发明的另一个实施方案中,治疗剂与标记物(其可以是用氘标记或未标记)相关联,其又将在呼吸中产生容易测量的标记物。